lilly glp-1 to pour $6.5 billion into pill manufacturing site US approves new oral weight-loss
Description
Chen, L
A meta-analysis of randomized controlled trials evaluating GLP-1 receptor agonists in PCOS women with obesity confirmed that these medications significantly reduce BMI, waist circumference, serum triglycerides and total testosterone
It's not fun
Multiple manufacturers including Sandoz, Apotex, and Teva have submitted applications for generic semaglutide products
The doctor suggested I start losing weight to improve my health
Obes Surg 28:35533558 Bonnet JB et al (2024) Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery
